ImetelChat

Sept 13th 10AM, here's the link: https://edge.media-server.com/m6/p/rhr5yhf6

We don't know for sure that Geron will even be mentioned by name but many hints abound not the least of which is that we are approaching a firm deadline for the CD from Janssen, and Janssen has emphasized a focus on heme related disease. Of course they have several other agents to discuss in their Pharma pipeline as well, but many including myself are hopeful this is where the unveiling of the future of the Imetelstat program will become clear. Best wishes to all, bp

Something that caught my attention on the slide that lists Imetelstat as an NME. MF is listed first (blue for NME) and MDS is listed as a line extension(black). So wouldn’t this mean MF goes for NDA first?

Jpheis, agree totally, MF data much further along, no phase III planed etc, bp